IL126176A - Pharmaceutical packaging unit containing estrogen and progesterone antagonist for stepwise hormonal therapy - Google Patents

Pharmaceutical packaging unit containing estrogen and progesterone antagonist for stepwise hormonal therapy

Info

Publication number
IL126176A
IL126176A IL12617697A IL12617697A IL126176A IL 126176 A IL126176 A IL 126176A IL 12617697 A IL12617697 A IL 12617697A IL 12617697 A IL12617697 A IL 12617697A IL 126176 A IL126176 A IL 126176A
Authority
IL
Israel
Prior art keywords
estrogen
pharmaceutical kit
dosage units
progesterone antagonist
hydroxy
Prior art date
Application number
IL12617697A
Other languages
English (en)
Hebrew (he)
Other versions
IL126176A0 (en
Original Assignee
Schering Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Schering Ag filed Critical Schering Ag
Publication of IL126176A0 publication Critical patent/IL126176A0/xx
Publication of IL126176A publication Critical patent/IL126176A/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
    • A61P5/30—Oestrogens

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Diabetes (AREA)
  • Endocrinology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Steroid Compounds (AREA)
  • Medicinal Preparation (AREA)
IL12617697A 1996-03-11 1997-03-11 Pharmaceutical packaging unit containing estrogen and progesterone antagonist for stepwise hormonal therapy IL126176A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE19610635A DE19610635A1 (de) 1996-03-11 1996-03-11 Sequentielle Estrogen/Progesteronantagonist-Kombination für die Hormonersatz-Therapie
PCT/DE1997/000580 WO1997033589A1 (de) 1996-03-11 1997-03-11 Sequentielle estrogen/progesteronantagonist-kombination für die hormonersatz-therapie

Publications (2)

Publication Number Publication Date
IL126176A0 IL126176A0 (en) 1999-05-09
IL126176A true IL126176A (en) 2004-12-15

Family

ID=7788657

Family Applications (1)

Application Number Title Priority Date Filing Date
IL12617697A IL126176A (en) 1996-03-11 1997-03-11 Pharmaceutical packaging unit containing estrogen and progesterone antagonist for stepwise hormonal therapy

Country Status (16)

Country Link
EP (1) EP0889727B1 (pt)
JP (1) JP2000506175A (pt)
KR (1) KR19990087672A (pt)
AT (1) ATE319454T1 (pt)
AU (1) AU2691197A (pt)
BR (1) BR9708162A (pt)
CA (1) CA2248841C (pt)
DE (2) DE19610635A1 (pt)
DK (1) DK0889727T3 (pt)
ES (1) ES2260792T3 (pt)
HU (1) HUP9901474A3 (pt)
IL (1) IL126176A (pt)
NO (1) NO324613B1 (pt)
PL (1) PL328809A1 (pt)
PT (1) PT889727E (pt)
WO (1) WO1997033589A1 (pt)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19834931A1 (de) * 1998-07-28 2000-02-24 Jenapharm Gmbh Verwendung von biogenen Estrogenen zur Hormonsubstitutionstherapie
CO5200773A1 (es) * 1999-08-31 2002-09-27 Jenapharm Gmbh And Co Kg Mesoprogestinas (moduladores de receptores para progestero- na) como componente de composiciones utilizadas para la terapia de sustitucion hormonal (trh)
US7629334B1 (en) 1999-08-31 2009-12-08 Bayer Schering Pharma Aktiengesellschaft Mesoprogrestins (progesterone receptor modulations) as a component of compositions for hormone replacement therapy (HRT)
IL145838A (en) * 2000-10-16 2008-11-03 Pfizer Prod Inc Use of an estrogen agonist / antagonist to produce a drug for the treatment of vaginitis
ES2233570T3 (es) * 2000-11-30 2005-06-16 Pfizer Products Inc. Composicion que contiene agonistas/antagosnistas de estrogenos y testosterona para tratar un descenso en el nivel de la hormona testosterona.

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5468736A (en) * 1993-02-25 1995-11-21 The Medical College Of Hampton Road Hormone replacement therapy

Also Published As

Publication number Publication date
HUP9901474A2 (hu) 1999-09-28
NO324613B1 (no) 2007-11-26
IL126176A0 (en) 1999-05-09
DK0889727T3 (da) 2006-07-03
WO1997033589A1 (de) 1997-09-18
NO984166L (no) 1998-09-10
HUP9901474A3 (en) 2000-02-28
PT889727E (pt) 2006-07-31
BR9708162A (pt) 1999-07-27
PL328809A1 (en) 1999-02-15
EP0889727A1 (de) 1999-01-13
CA2248841C (en) 2008-07-22
JP2000506175A (ja) 2000-05-23
ATE319454T1 (de) 2006-03-15
AU2691197A (en) 1997-10-01
DE19610635A1 (de) 1997-09-18
DE59712593D1 (de) 2006-05-04
CA2248841A1 (en) 1997-09-18
ES2260792T3 (es) 2006-11-01
KR19990087672A (ko) 1999-12-27
EP0889727B1 (de) 2006-03-08
NO984166D0 (no) 1998-09-10

Similar Documents

Publication Publication Date Title
EP0912186B1 (en) Progestogen-anti-progestogen regimens
KR100365879B1 (ko) 프로게스테론길항제및게스타겐을포함하는자궁내막증식증또는자궁평활근종치료제
JPH09503774A (ja) 閉経直前及び閉経後の女性に対するホルモン置換療法用の黄体ホルモン拮抗物質及び部分的アゴニスト作用を有する抗エストロゲンの組合わせ
US6506390B2 (en) Progestogen-anti-progestogen regimens
CZ288062B6 (cs) Přípravek pro ženskou antikoncepci
CA2248841C (en) Sequential oestrogen/progesterone antagonist combination for hormone replacement therapy
US6642219B1 (en) Progestogen-antiprogestogen regimens
EP1605924B1 (en) Mesoprogestins (progesterone receptor modulators) as a component of compositions for hormone replacement therapy (hrt)
AU2003206424B2 (en) Sequential estrogen/progesterone antagonist combination for hormone replacement therapy
MXPA98007513A (en) Sequencial combination of estrogen / antagonist of progesterone for therapy of replacement of hormo
US7629334B1 (en) Mesoprogrestins (progesterone receptor modulations) as a component of compositions for hormone replacement therapy (HRT)

Legal Events

Date Code Title Description
FF Patent granted
KB Patent renewed
MM9K Patent not in force due to non-payment of renewal fees